OakChart

Amarin Corp ADR

AMRNHealthcare·Drug Manufacturers - General·Ireland·Micro·NASD·Nov 11 • 3:59 PM ET

11.71-0.04 (-0.34%)
2026-11-12 00:02 CET
Market cap
247.71 USD m
Revenue, TTM
176.02 USD m
Net income, TTM
-19.14 USD m
Free cash flow, TTM
37.53 USD m
EPS diluted, TTM
-0.92
P/E
-
Compare

Price

AMRN against its 20, 50 and 200-day averages
2050200beatmiss
12.0014.0016.00253K505KVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26AMRNclose 11.7120-day 11.8650-day 12.62200-day 14.1611.7152w high52w low

32.4% under the 52-week high of 17.31 on 23 Jan 2026. 52-week low 11.25 on 16 Oct 2026. Last 15 sessions, 17.2% high to low

Volume 1.10× normal · the line is the 50-bar volume average

Profile

AMRN
52-week range, 8% of the way up
11.2517.31

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Employees80
IPOApr 01, 1993
Beta0.79
ATR, 14d0.44
Rel volume1.10
Short float2.55%
Insider own0.02%
Inst own20.54%

Snapshot

6 groups

Valuation

Index-
Market Cap246.85M
Enterprise Value-71.38M
Income-19.14M
Sales176.02M
Book/sh21.08
Cash/sh15.35
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees80
IPOApr 01, 1993

Ratios

P/E-
Forward P/E-
PEG-
P/S1.40
P/B0.56
P/C0.76
P/FCF6.58
EV/EBITDA-
EV/Sales-0.41
Quick Ratio2.59
Current Ratio3.50
Debt/Eq0.01
LT Debt/Eq0.01
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.92
EPS next Y-0.63
EPS next Q-0.08
EPS this Y-1153.19%
EPS next Y44.30%
EPS next 5Y-
EPS past 3/5Y29.16% -14.55%
Sales past 3/5Y-16.59% -19.12%
EPS Y/Y TTM78.01%
Sales Y/Y TTM-22.43%
EPS Q/Q103.08%
Sales Q/Q-19.91%
EarningsOct 28 BMO
EPS/Sales Surpr.100.00% -9.63%

Ownership

Insider Own0.02%
Insider Trans0.00%
Inst Own20.54%
Inst Trans-0.77%
ROA-2.96%
ROE-4.24%
ROIC-4.25%
Gross Margin39.45%
Oper. Margin-13.98%
Profit Margin-10.87%
SMA20-1.28%
SMA50-7.21%
SMA200-17.33%
Trades-

Technical

Shs Outstand21.08M
Shs Float21.08M
Short Float2.55%
Short Ratio7.29
Short Interest0.54M
52W High17.31 -32.35%
52W Low11.25 4.09%
Volatility4.39% 3.79%
ATR (14)0.44
RSI (14)42.10
Beta0.79
Rel Volume1.10
Avg Volume73.77K
Volume81,273

Performance

Perf Week-4.41%
Perf Month1.12%
Perf Quarter-17.24%
Perf Half Y-22.04%
Perf YTD-16.09%
Perf Year-27.22%
Perf 3Y-19.17%
Perf 5Y-85.75%
Perf 10Y-81.47%
Recom5.00
Target Price13.00
Prev Close11.75
Price11.71
Change %-0.34%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Aug 21, 2026ResumedJJP MorganUnderweight$13+11.0%
Nov 20, 2023ResumedJJP MorganUnderweight
Oct 25, 2023DowngradeJJefferiesBuy → Hold$3 → $1-91.5%
Jan 06, 2023UpgradeJJefferiesHold → Buy$1.30 → $3-74.4%
May 06, 2022DowngradeJJP MorganNeutral → Underweight
May 05, 2022DowngradeSSVB LeerinkOutperform → Mkt Perform$10 → $3-74.4%
May 05, 2022DowngradeHH.C. WainwrightBuy → Neutral$10 → $3-74.4%
May 04, 2022DowngradeNNorthland CapitalOutperform → Market Perform
May 12, 2021DowngradeGGoldmanNeutral → Sell$6 → $5-57.3%
Sep 29, 2020ResumedJJP MorganNeutral

Peers

Mkt cap
TickerCompanyMkt cap
ARWRArrowhead Pharmaceuticals Inc6.97B
IONSIonis Pharmaceuticals Inc4.72B
OGNOrganon & Co3.65B
NAMSNewAmsterdam Pharma Company NV2.48B
RDYDr. Reddy's Laboratories Ltd ADR12.36B
CRDLCardiol Therapeutics Inc121.87M
LXRXLexicon Pharmaceuticals Inc832.59M
ANIPANI Pharmaceuticals Inc1.63B
KNSAKiniksa Pharmaceuticals International Plc7.52B
AMRXAmneal Pharmaceuticals Inc7.56B

Held by

AUM
TickerCompanyAUM
SPDWState Street SPDR Portfolio Developed World ex-US ETFAUM: 41.64B
GWXState Street SPDR S&P International Small Cap ETFAUM: 906.57M

News

latest 14 of 200
  • Amarin Presents New Cardiovascular Risk Data on Lipoprotein(a) and EPA at AHA Scientific Sessions 2026 (InvestorsHub)
  • Amarin Highlights New Data on Lipoprotein(a) and other Apolipoprotein B Containing Lipoproteins at American Heart Association (AHA) Scientific Sessions 2026 (GlobeNewswire)
  • Amarin: Q3 Earnings Snapshot (Associated Press) +6.65%
  • Amarin Returns to Quarterly Profit as Cost Reductions Offset 20% Revenue Decline (InvestorsHub)
  • Amarin Posts First Profit In Two Years On Cost Cuts, But Shrinking Revenue Undercuts The Beat (Earnings Whispers)
  • Amarin Reports 2026 Third Quarter Financial Results, Achieves Positive Net Income (GlobeNewswire)
  • Amarin Provides Update on University of Leeds Sponsored Phase 3 EPA for Metastasis Trial 2 (EMT2) Evaluating VAZKEPA/VASCEPA (icosapent ethyl) Capsules on Top of Standard of Care Treatment in Patients Undergoing Liver Resection for Colorectal Cancer Liver Metastases (CRCLM) (GlobeNewswire)
  • Amarin's Leaner Model Faces A Proof Test As Europe Must Offset US Erosion (Earnings Whispers)
  • Amarin to Report Third Quarter 2026 Financial Results and Host Conference Call on October 28, 2026 (GlobeNewswire)
  • Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year? (Quartz)
  • Amarin Highlights New REDUCE-IT and Mechanistic Data Presented at European Society of Cardiology (ESC) Congress 2026 (GlobeNewswire)
  • New REDUCE-IT Legacy Analysis Presented at European Society of Cardiology (ESC) Congress 2026 Suggests Persistent Cardiovascular Benefit Following Icosapent Ethyl Treatment Cessation in Adherent Patients (GlobeNewswire)
  • Amarin to Present New REDUCE-IT and EPA Analyses at ESC Congress 2026 (InvestorsHub)
  • New Analyses from REDUCE-IT and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2026 (GlobeNewswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-280.000-0.0970.00039.5543.762
2026Q22026-07-29-0.020-0.010-0.36842.2144.551
2026Q12026-04-29-0.0300.010-0.50145.1343.772
2025Q42026-02-250.0000.034-0.05949.2254.593
2025Q32025-10-29-0.020-0.430-0.37049.6743.103
2025Q22025-07-30-0.030-0.250-0.69172.7453.763
2025Q12025-05-07-0.040-0.770-0.76241.0450.752
2024Q42025-03-12-2.400-1.057-2.34262.3135.953
2024Q32024-10-30-1.200-1.110-1.23542.3043.884
2024Q22024-07-310.000-0.8500.07467.4951.024
2024Q12024-05-01-0.400-0.600-0.48555.1657.054
2023Q42024-02-29-0.200-0.538-0.28674.7166.265
2023Q32023-11-01-1.000-0.900-0.94066.0658.654
2023Q22023-08-02-0.800-0.800-0.86480.1774.525
2023Q12023-05-03-0.800-0.590-0.81885.9881.216
2022Q42023-03-010.000-0.1660.04390.2587.246

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2018FY-7.800-6.980-7.822229.21225.73
2019FY-1.400-2.034-1.328429.76422.47
2020FY-1.000-1.310-0.950614.06610.72
2021FY0.400-0.6000.384583.19579.69
2022FY-5.200-4.750-5.272369.19365.97
2023FY-3.000-3.126-2.911306.91298.42
2024FY-4.000-2.809-4.002228.61202.26
2025FY-0.090-0.662-0.090213.65222.45
2026FY--1.128--183.35
2027FY--0.628--189.05
2028FY--0.827--185.11
2029FY-0.190--234.1

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-10-2910049.9049.9049.90
2026Q4S2026-10-2820145.1240.3449.90
2026Q4S2026-08-2020046.7343.5649.90
2026Q4S2026-07-2910043.5643.5643.56
2026Q4S2026-07-1310043.9543.9543.95
2026Q4S2026-07-0311043.9543.9543.95
2026Q4S2026-04-2921048.5743.9553.20
2026Q4S2026-03-0520045.4637.9253.00
2026Q4S2026-02-2710053.0053.0053.00
2026Q4R2026-10-29100-0.08-0.08-0.08
2026Q4R2026-10-28210-0.04-0.080.00
2026Q4R2026-10-12200-0.05-0.08-0.01
2026Q4R2026-08-20201-0.05-0.08-0.01
2026Q4R2026-07-29101-0.01-0.01-0.01

Estimate history

EPS, annual-5.054-7.822-1.328-0.950.384-5.272-2.911-4.002-1.874-0.9163
Period201720182019202020212022202320242025TTM
EPS, quarterly-1.235-2.342-0.762-0.691-0.37-0.059-0.501-0.3680.011
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual183.046228.826431.534618.837583.118368.965308.101228.71214.145176.02
Period201720182019202020212022202320242025TTM
Sales, quarterly42.73261.72842.17873.64149.3649.14845.05642.28739.53
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual13.55116.29318.00519.62719.8320.21720.44120.57920.81121.082
Period201720182019202020212022202320242025MRQ
Shares, quarterly20.56320.57920.71820.7720.79820.81120.9821.00221.082
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue176.02214.15228.71308.10368.97583.12618.84431.53228.83
Cost of Goods Sold Incl. D&A106.5796.03150.31105.51129.72124.17134.5297.2855.12
Gross Profit69.45118.1278.40202.59239.24458.95484.32334.25173.71
Selling, General and Administrative Excl. Other94.05132.09170.24220.04331.53434.73504.12358.63281.75
Research and Development16.3916.8217.8619.3327.3026.4537.2133.6755.14
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-24.61-13.97-91.84-17.46-92.2924.22-19.81-24.38-108.04
Interest Expense0.000.000.000.000.000.132.636.658.86
Unusual Expense7.4236.310.0050.3913.5213.720.00-0.00
Net Income Before Taxes-17.13-36.13-77.23-53.88-103.7411.29-17.39-22.57-116.15
Income Taxes2.012.764.995.462.003.560.750.160.10
Consolidated Net Income-19.14-38.89-82.22-59.34-105.747.73-18.14-22.74-116.25
Net Income From Continuing Operations-19.14-38.89-82.22-59.34-105.747.73-18.14-22.74-116.25
Net Income-19.14-38.89-82.22-59.34-105.747.73-18.14-22.74-116.25
EPS (Recurring)-0.65-0.65-4.00-1.18-4.800.86-0.95-1.33-7.82
EPS (Basic, Before Extraordinaries)-0.92-1.87-4.00-2.91-5.270.39-0.95-1.33-7.82
EPS (Diluted)-0.92-1.87-4.00-2.91-5.270.38-0.95-1.33-7.82
EBITDA-21.99-10.94-88.82-14.48-89.1927.07-17.75-23.52-107.37
Non-Operating Income (Expense)14.8914.1614.6013.972.060.925.048.460.75
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense6.2812.2215.5012.4120.7029.9246.1731.0415.21
Price To Earnings Ratio-----171.94---
Price To Sales Ratio1.581.350.871.151.322.333.0217.0217.68
Gross Margin39.4555.1634.2865.7564.8478.7178.2677.4675.91
Operating Margin-13.98-6.53-40.15-5.67-25.014.15-3.20-5.65-47.22
Net Margin-10.87-18.16-35.95-19.26-28.661.33-2.93-5.27-50.80
Shares Outstanding21.0820.8120.5820.4420.2219.8319.6318.0116.29
Market Capitalization247.71247.71199.62355.44488.631,336.541,919.517,720.634,434.82

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue39.5342.2945.0649.1549.3673.6442.1861.73
Cost of Goods Sold Incl. D&A24.0027.9127.9526.7128.1523.3917.6871.94
Gross Profit15.5314.3817.1022.4321.2150.2524.49-10.21
Selling, General and Administrative Excl. Other17.8926.3725.1024.6922.8943.3941.3141.83
Research and Development3.564.144.024.663.324.244.605.20
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-2.36-11.99-8.00-2.26-1.696.86-16.82-52.04
Interest Expense0.000.000.000.000.000.000.000.00
Unusual Expense0.000.043.324.069.3523.040.000.00
Net Income Before Taxes0.31-7.88-8.71-0.85-8.06-13.62-13.68-49.44
Income Taxes0.07-0.221.790.37-0.370.702.07-1.28
Consolidated Net Income0.24-7.66-10.49-1.22-7.69-14.31-15.76-48.17
Net Income From Continuing Operations0.24-7.66-10.49-1.22-7.69-14.31-15.76-48.17
Net Income0.24-7.66-10.49-1.22-7.69-14.31-15.76-48.17
EPS (Recurring)0.01-0.37-0.390.08-0.060.09-0.76-2.34
EPS (Basic, Before Extraordinaries)0.01-0.37-0.50-0.06-0.37-0.69-0.76-2.34
EPS (Diluted)0.01-0.37-0.50-0.06-0.37-0.69-0.76-2.34
EBITDA-1.72-11.35-7.36-1.56-0.827.60-16.09-51.30
Non-Operating Income (Expense)2.674.152.615.472.972.573.142.59
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense1.201.842.001.231.464.593.432.95
Price To Sales Ratio1.581.791.391.351.501.530.860.87
Gross Margin39.3034.0037.9645.6542.9768.2358.07-16.54
Operating Margin-5.97-28.36-17.75-4.59-3.429.31-39.88-84.30
Net Margin0.62-18.12-23.29-2.49-15.58-19.44-37.36-78.03
Shares Outstanding21.0821.0020.9820.8120.8020.7720.7220.58
Market Capitalization247.71334.42300.92290.24340.21336.05185.68199.62

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments302.79294.52321.18309.88458.05504.85648.50250.7374.24
Short Term Receivables126.83122.28133.56130.99163.65154.57116.4366.5245.32
Inventories195.91166.05258.62228.73234.68188.8676.7757.8030.26
Other Current Assets24.3512.5511.6219.4922.3530.9513.312.943.46
Total Current Assets649.88595.40724.98689.10878.73879.23855.00378.00153.27
Net Property, Plant & Equipment6.477.618.429.959.0910.0710.870.060.03
Total Investments and Advances0.000.000.001.2735.0062.470.000.000.00
Intangible Assets13.3616.3919.3021.7823.5513.8215.267.488.13
Deferred Tax Assets--------1.74
Other Assets1.0565.9578.97164.08121.710.431.070.170.17
Total Assets670.77685.35831.68886.181,068.07966.02882.21385.71163.34
Short Term Debt Incl. Current Port. of LT Debt0.000.000.0010.031.770.6550.4934.2422.83
Accounts Payable45.3540.3752.7664.60114.92105.8849.9537.6325.16
Other Current Liabilities149.10139.58206.52184.84253.99200.92141.8185.3960.55
Total Current Liabilities194.46179.95259.28259.48370.68307.44242.25157.26108.53
Long Term Debt6.087.728.7410.028.589.159.4446.1199.83
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities--------1.74
Other Liabilities10.9611.5011.5721.3521.7121.9222.2530.0118.34
Total Liabilities211.49199.17279.59290.85400.97338.52273.95233.38228.44
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.0021.8521.8524.36
Common Equity459.28486.18552.10595.33667.10627.50586.41130.48-89.46
Total Shareholders Equity459.28486.18552.10595.33667.10627.50608.26152.33-65.10
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity459.28486.18552.10595.33667.10627.50608.26152.33-65.10
Total Liabilities & Stockholders Equity670.77685.35831.68886.181,068.07966.02882.21385.71163.34
Book Value Per Share22.0723.6227.0129.4533.6431.9732.578.01-6.60
Tangible Book Value Per Share21.4322.8326.0628.3732.4531.2731.727.55-7.20
Full-Time Employees802752753655601,000965530241
Price to Book Ratio0.560.410.640.832.003.0613.1733.99-15.41
Return on Assets-5.74-10.84-6.91-10.820.76-1.96-3.59-42.35-41.18
Return on Equity-8.23-15.84-10.34-16.751.19-2.94-5.98-266.53-
Return on Invested Capital-8.36-16.65-10.58-17.471.14-2.85-3.68-58.58-197.53
Quick Ratio2.332.391.801.771.742.253.212.041.13
Current Ratio3.343.312.802.662.372.863.532.401.41

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-19.09-38.89-82.22-59.34-105.747.73-18.14-22.74-116.25
Depreciation2.613.043.012.983.092.862.050.860.67
Other Funds (Non Cash)5.4510.3211.9812.0026.6738.8648.4232.7020.95
Funds from Operations-11.03-25.54-67.22-44.37-75.9749.4532.3410.82-94.63
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital48.5632.2836.1951.27-104.01-115.98-54.25-20.220.08
Cash from Operating Activities37.536.74-31.036.91-179.98-66.53-21.92-9.40-94.54
Capital Expenditures0.000.000.00-0.54-0.600.00-0.25-2.49-0.06
Net Assets From Acquisitions0.000.000.000.000.000.000.000.00-
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00-
Purchase or Sale of Investments-1.148.85-46.00-25.09175.78104.09-379.640.000.00
Purchase of Investments-199.98-200.94-278.89-215.93-81.58-290.16-683.980.000.00
Sale Or Maturity of Investments198.83209.79232.90190.84257.36394.25304.340.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-1.148.85-46.00-25.62175.18104.09-379.90-2.49-0.06
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock0.140.140.132.220.664.577.17468.68291.79
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock0.140.140.132.220.664.577.17468.68291.79
Proceedsfrom Stock Options0.140.140.120.330.601.651.97444.101.04
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00-51.24-31.78-14.70
Change in Long Term Debt0.000.000.000.000.000.000.00-0.00
Issuance of Long Term Debt0.000.000.000.000.000.000.00-0.00
Reduction of Long Term Debt0.000.000.000.000.000.000.00-0.00
Net Financing Active Other Cash Flow-2.90-2.18-1.57-1.99-1.04-9.64-15.30-25.59-6.29
Other Financing Activities Uses-2.90-2.18-1.57-1.99-1.04-9.64-15.30-25.59-6.29
Cash from Financing Activities-2.76-2.04-1.440.23-0.38-5.07-59.37411.31270.79
Net Change in Cash33.6313.55-78.47-18.48-5.1832.49-461.18399.41176.19
Free Cash Flow37.536.74-31.036.88-179.98-66.53-22.17-11.89-94.60
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.00--
Price to Free Cash Flow7.4142.94-51.53-----
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments323.58314.85308.02302.79286.89299.00
Short Term Receivables112.9794.32108.05126.83127.31119.13
Inventories158.85164.07183.59195.91184.70171.24
Other Current Assets17.4729.5226.3624.3529.4317.44
Total Current Assets612.88602.76626.02649.88628.33606.82
Net Property, Plant & Equipment6.085.566.016.477.207.65
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets11.4612.0912.7313.3614.0714.93
Other Assets3.673.951.011.0510.2140.72
Total Assets634.08624.36645.76670.77659.81670.13
Short Term Debt Incl. Current Port. of LT Debt0.000.000.000.000.000.00
Accounts Payable40.4318.8048.1545.3536.7144.71
Other Current Liabilities134.71145.40131.49149.10145.52141.24
Total Current Liabilities175.14164.19179.64194.46182.23185.95
Long Term Debt5.355.255.586.086.737.34
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities9.1811.3011.1210.9611.9611.92
Total Liabilities189.67180.75196.35211.49200.92205.20
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity444.41443.62449.41459.28458.89464.92
Total Shareholders Equity444.41443.62449.41459.28458.89464.92
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity444.41443.62449.41459.28458.89464.92
Total Liabilities & Stockholders Equity634.08624.36645.76670.77659.81670.13
Book Value Per Share21.0821.1221.4222.0722.0622.38
Tangible Book Value Per Share20.5420.5520.8121.4321.3921.67
Full-Time Employees---80--
Price to Book Ratio0.560.740.660.630.730.71
Return on Assets-2.96-4.18-5.18-5.75-12.18-14.10
Return on Equity-4.24-5.96-7.31-8.25-17.35-20.38
Return on Invested Capital0.05-1.71-2.31-0.26-1.65-3.03
Quick Ratio2.592.672.462.332.432.34
Current Ratio3.503.673.483.343.453.26

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income0.25-7.66-10.49-1.18-7.62-14.34
Depreciation0.640.640.640.700.860.74
Other Funds (Non Cash)1.041.631.800.981.095.12
Funds from Operations1.93-5.39-8.060.50-5.66-8.47
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital7.2912.0114.4414.82-7.1025.16
Cash from Operating Activities9.226.616.3815.32-12.7616.69
Capital Expenditures0.000.000.000.000.000.00
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments4.566.12-8.28-3.54-12.2912.57
Purchase of Investments-59.01-39.81-50.71-50.45-68.97-38.42
Sale Or Maturity of Investments63.5645.9342.4346.9156.6850.99
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities4.566.12-8.28-3.54-12.2912.57
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-0.000.060.000.08-0.000.06
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock-0.000.060.000.08-0.000.06
Proceedsfrom Stock Options-0.000.060.000.08-0.000.06
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow-0.83-0.31-1.68-0.08-0.24-0.73
Other Financing Activities Uses-0.83-0.31-1.68-0.08-0.24-0.73
Cash from Financing Activities-0.83-0.25-1.68-0.00-0.24-0.67
Net Change in Cash12.9512.49-3.5911.78-25.3028.59
Free Cash Flow9.226.616.3815.32-12.76-
Price to Free Cash Flow7.4121.34----

Revenue breakdown

Licensing And Royalty2024: 24.02M 2025: 30.89M
Product2024: 204.59M 2025: 182.75M
Ireland2024: 228.61M 2025: 213.65M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-302.55%0.5M21.1M68.52K
2026-10-152.52%0.5M21.1M65.51K
2026-09-302.50%0.5M21.1M66.45K
2026-09-152.49%0.5M21.1M75.15K
2026-08-312.42%0.5M21.1M84.12K
2026-08-142.51%0.5M20.9M73.19K
2026-07-312.54%0.5M20.9M77.02K
2026-07-152.46%0.5M20.9M84.60K
2026-06-302.60%0.5M20.9M76.85K
2026-06-152.94%0.6M20.9M67.37K
2026-05-292.99%0.6M20.9M64.72K
2026-05-152.97%0.6M20.9M74.14K
2026-04-303.23%0.7M20.9M74.02K
2026-04-152.06%0.4M20.7M72.85K
2026-03-312.20%0.5M20.7M83.72K
2026-03-132.16%0.4M20.7M93.65K
2026-02-272.11%0.4M20.7M92.55K
2026-02-131.98%0.4M20.7M88.17K
2026-01-302.02%0.4M20.7M93.80K
2026-01-151.98%0.4M20.7M109.91K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call1.008.5012.800.000.0000.000.000.994-0.0150.000
call2.007.5011.800.0032.2070.000.000.990-0.0160.000
call3.006.5010.800.0017.8180.000.000.957-0.0750.002
call4.006.008.900.009.5170.000.000.943-0.0760.002
call5.004.508.800.0010.7240.000.000.927-0.0750.003
call6.003.507.800.008.8850.000.000.909-0.0730.003
call9.002.103.903.733.2622.000.000.826-0.0600.005
call10.001.202.900.002.6340.000.000.739-0.0730.006
call11.000.401.950.002.2310.000.000.643-0.0690.007
call12.000.001.050.851.61442.000.000.511-0.0650.007
call13.000.050.500.151.3251840.000.345-0.0510.007
call14.000.000.550.101.5883300.000.295-0.0540.007
call15.000.002.000.172.00297.000.000.262-0.0680.006
call16.000.000.750.051.8954.000.000.182-0.0520.005
call17.000.002.000.052.12012.000.000.168-0.0550.005
call18.000.000.750.052.19472.000.000.158-0.0520.005
call19.000.002.000.002.5120.000.000.149-0.0600.004
call20.000.001.100.052.0761074.000.068-0.0280.002
call25.000.002.000.092.6995.000.000.056-0.0310.002
put1.000.000.750.008.6070.000.00-0.006-0.0150.000
put2.000.000.750.006.0750.000.00-0.010-0.0160.000
put3.000.000.750.007.9940.000.00-0.043-0.0750.002
put4.000.000.750.006.4040.000.00-0.057-0.0760.002
put5.000.000.750.005.2320.000.00-0.073-0.0750.003
put6.000.000.750.004.2990.000.00-0.091-0.0720.003
put9.000.000.750.052.22262.000.00-0.174-0.0590.005
put10.000.000.750.452.1680.000.00-0.261-0.0720.006
put11.000.000.850.581.67452.000.00-0.357-0.0680.007
put12.000.001.250.851.5061450.00-0.505-0.0530.007
put13.000.802.201.561.93321.0020.00-0.655-0.0490.007
put14.001.603.201.552.3291.000.00-0.706-0.0590.006
put15.002.804.500.003.1010.000.00-0.738-0.0660.006
put16.003.705.300.003.1130.000.00-0.818-0.0500.005
put17.004.607.000.004.3940.000.00-0.832-0.0530.005
put18.005.007.600.004.0720.000.00-0.842-0.0560.004
put19.006.109.000.004.8780.000.00-0.851-0.0580.004
put20.007.5010.000.005.0910.000.00-0.932-0.0260.002
put25.0011.7015.000.005.9570.000.00-0.944-0.0280.002

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-2810-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-288-KCurrent report2026-10-28SEC
2026-08-27SCHEDULE 13D/ASEC
2026-08-034Statement of changes in beneficial ownership of securities2026-08-01SEC
2026-07-2910-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-298-KCurrent report2026-07-29SEC
2026-07-154Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-07-154Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-07-154Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-07-154Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-06-304Statement of changes in beneficial ownership of securities2026-06-26SEC
2026-05-158-KCurrent report2026-05-13SEC
2026-04-2910-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-04-298-KCurrent report2026-04-29SEC
2026-04-224Statement of changes in beneficial ownership of securities2026-04-18SEC
2026-04-214Statement of changes in beneficial ownership of securities2026-04-18SEC
2026-04-214Statement of changes in beneficial ownership of securities2026-04-18SEC
2026-04-214Statement of changes in beneficial ownership of securities2026-04-18SEC
2026-04-214Statement of changes in beneficial ownership of securities2026-04-18SEC
2026-04-214Statement of changes in beneficial ownership of securities2026-04-18SEC
2026-04-214Statement of changes in beneficial ownership of securities2026-04-18SEC
2026-04-10ARSAnnual report to security holders. 2025-12-31SEC
2026-04-10DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-04-10SEC
2026-04-024Statement of changes in beneficial ownership of securities2026-04-01SEC
2026-03-30PRE 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-03-30SEC
2026-03-278-KCurrent report2026-03-25SEC
2026-03-0210-KAnnual report pursuant to Section 13 or 15(d)2025-12-31SEC
2026-02-258-KCurrent report2026-02-25SEC
2026-02-034Statement of changes in beneficial ownership of securities2026-01-31SEC
2026-02-034Statement of changes in beneficial ownership of securities2026-01-31SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
Sarissa Capital Management LP7.98%
ACADIAN ASSET MANAGEMENT LLC3.47%
Kynam Capital Management, LP2.54%
MORGAN STANLEY1.07%
Brooklands Fund Management Ltd1.03%
Waterfront Wealth Inc.1.01%
Eversept Partners, LP0.69%
MILLENNIUM MANAGEMENT LLC0.55%
TWO SIGMA INVESTMENTS, LP0.48%
CITADEL ADVISORS LLC0.45%

Funds

Fund% owned
Old Westbury Small & Mid Cap Strategies Fund0.28%
State Street(R) SPDR(R) Portfolio Developed World ex-US ETF0.08%
SIT International Equity Fund0.07%
VOYA MULTI-MANAGER INTERNATIONAL SMALL CAP FUND0.05%
Fidelity Nasdaq Composite Index Fund0.05%
Nomura Healthcare Fund0.05%
State Street(R) SPDR(R) S&P(R) International Small Cap ETF0.04%
Steward Values Enhanced International Fund0.03%
TIFF MULTI-ASSET FUND0.01%
Blackstone Alternative Multi-Strategy Fund0.00%

OakChart. AMRN. Cached 15 minutes.

Some panels did not load: insider.